Humana Statistics
Total Valuation
Humana has a market cap or net worth of $43.69 billion. The enterprise value is $51.54 billion.
| Market Cap | 43.69B |
| Enterprise Value | 51.54B |
Important Dates
The last earnings date was Wednesday, July 29, 2026, before market open.
| Earnings Date | Jul 29, 2026 |
| Ex-Dividend Date | Jun 26, 2026 |
Share Statistics
Humana has 120.08 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 120.08M |
| Shares Outstanding | 120.08M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 0.12% |
| Owned by Institutions (%) | 99.56% |
| Float | 119.82M |
Valuation Ratios
The trailing PE ratio is 34.36 and the forward PE ratio is 29.54. Humana's PEG ratio is 1.53.
| PE Ratio | 34.36 |
| Forward PE | 29.54 |
| PS Ratio | 0.30 |
| Forward PS | 0.26 |
| PB Ratio | 2.27 |
| P/TBV Ratio | 5.79 |
| P/FCF Ratio | 22.42 |
| P/OCF Ratio | 17.21 |
| PEG Ratio | 1.53 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.79, with an EV/FCF ratio of 26.45.
| EV / Earnings | 40.30 |
| EV / Sales | 0.35 |
| EV / EBITDA | 14.79 |
| EV / EBIT | 19.05 |
| EV / FCF | 26.45 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.74 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 4.23 |
| Debt / FCF | 7.56 |
| Interest Coverage | 3.84 |
Financial Efficiency
Return on equity (ROE) is 6.89% and return on invested capital (ROIC) is 8.13%.
| Return on Equity (ROE) | 6.89% |
| Return on Assets (ROA) | 3.90% |
| Return on Invested Capital (ROIC) | 8.13% |
| Return on Capital Employed (ROCE) | 7.91% |
| Weighted Average Cost of Capital (WACC) | 7.21% |
| Revenue Per Employee | $2.17M |
| Profits Per Employee | $19,072 |
| Employee Count | 67,060 |
| Asset Turnover | 2.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Humana has paid $298.00 million in taxes.
| Income Tax | 298.00M |
| Effective Tax Rate | 18.71% |
Stock Price Statistics
The stock price has increased by +39.16% in the last 52 weeks. The beta is 0.74, so Humana's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +39.16% |
| 50-Day Moving Average | 367.65 |
| 200-Day Moving Average | 265.26 |
| Relative Strength Index (RSI) | 40.96 |
| Average Volume (20 Days) | 1,482,457 |
Short Selling Information
The latest short interest is 4.25 million, so 3.54% of the outstanding shares have been sold short.
| Short Interest | 4.25M |
| Short Previous Month | 6.32M |
| Short % of Shares Out | 3.54% |
| Short % of Float | 3.55% |
| Short Ratio (days to cover) | 2.77 |
Income Statement
In the last 12 months, Humana had revenue of $145.68 billion and earned $1.28 billion in profits. Earnings per share was $10.59.
| Revenue | 145.68B |
| Gross Profit | 19.89B |
| Operating Income | 3.35B |
| Pretax Income | 1.59B |
| Net Income | 1.28B |
| EBITDA | 3.49B |
| EBIT | 2.71B |
| Earnings Per Share (EPS) | $10.59 |
Balance Sheet
The company has $23.87 billion in cash and $14.74 billion in debt, with a net cash position of -$7.85 billion or -$65.38 per share.
| Cash & Cash Equivalents | 23.87B |
| Total Debt | 14.74B |
| Net Cash | -7.85B |
| Net Cash Per Share | -$65.38 |
| Equity (Book Value) | 19.28B |
| Book Value Per Share | 160.00 |
| Working Capital | 17.08B |
Cash Flow
In the last 12 months, operating cash flow was $2.54 billion and capital expenditures -$590.00 million, giving a free cash flow of $1.95 billion.
| Operating Cash Flow | 2.54B |
| Capital Expenditures | -590.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 2.12B |
| Free Cash Flow | 1.95B |
| FCF Per Share | $16.23 |
Margins
Gross margin is 13.65%, with operating and profit margins of 2.30% and 0.88%.
| Gross Margin | 13.65% |
| Operating Margin | 2.30% |
| Pretax Margin | 1.09% |
| Profit Margin | 0.88% |
| EBITDA Margin | 2.39% |
| EBIT Margin | 1.86% |
| FCF Margin | 1.34% |
Dividends & Yields
This stock pays an annual dividend of $3.54, which amounts to a dividend yield of 0.97%.
| Dividend Per Share | $3.54 |
| Dividend Yield | 0.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 33.43% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 0.90% |
| Earnings Yield | 2.93% |
| FCF Yield | 4.46% |
Analyst Forecast
The average price target for Humana is $407.83, which is 12.08% higher than the current price. The consensus rating is "Buy".
| Price Target | $407.83 |
| Price Target Difference | 12.08% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 11.73% |
| EPS Growth Forecast (3Y) | 16.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 1, 1991. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Aug 1, 1991 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |